Are Triglyceride-Rich Lipoprotein ApoB Particles Really 4 Times More Atherogenic Than LDL ApoB Particles?
Journal of the American College of Cardiology · 2024
DOI: 10.1016/j.jacc.2024.07.033 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of the American College of Cardiology, 2024. Verfasst von Allan D Sniderman. Beteiligte Einrichtung: Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada. …. Hauptthemen laut MEDLINE: Atherosclerosis, Triglycerides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada. Electronic address: allansniderman@hotmail.com.
Zitieren
APA
Sniderman, A. D. (2024). Are Triglyceride-Rich Lipoprotein ApoB Particles Really 4 Times More Atherogenic Than LDL ApoB Particles?. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.07.033
Vancouver
Sniderman AD. Are Triglyceride-Rich Lipoprotein ApoB Particles Really 4 Times More Atherogenic Than LDL ApoB Particles?. Journal of the American College of Cardiology. 2024. doi:10.1016/j.jacc.2024.07.033
BibTeX
@article{Sniderman2024,
author = {Sniderman, Allan D},
title = {Are Triglyceride-Rich Lipoprotein ApoB Particles Really 4 Times More Atherogenic Than LDL ApoB Particles?},
journal = {Journal of the American College of Cardiology},
year = {2024},
doi = {10.1016/j.jacc.2024.07.033}
}
EUVIMED